Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Universal influenza vaccine - Icahn School of Medicine at Mount Sinai

Next Previous
X
Search
Drug Profile

Universal influenza vaccine - Icahn School of Medicine at Mount Sinai

Alternative Names: cHA based vaccine - Icahn School of Medicine at Mount Sinai; Universal flu vaccine - Icahn School of Medicine at Mount Sinai

Latest Information Update: 28 Nov 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Icahn School of Medicine at Mount Sinai
  • Class Adjuvants; Influenza virus vaccines
  • Mechanism of Action Immunostimulants; Toll-like receptor 9 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Influenza virus infections

Most Recent Events

  • 28 Nov 2023 No recent reports of development identified for preclinical development in Influenza-virus-infections(Prevention) in USA
  • 16 Jul 2020 Dynavax Technologies collaborates with Icahn School of Medicine at Mount Sinai to co-develop and co-promote the universal influenza vaccine in USA for influenza virus infection
  • 16 Jul 2020 Icahn School of Medicine at Mount Sinai along with Dynavax Technologies plans to file an IND application with the US FDA in USA for Influenza virus infection (Prevention)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top